Cancer Biopsy

Cancer is a heterogeneous genetic disease, and excisional biopsies provide only a snapshot in time of some of the rapid, dynamic genetic changes occurring in tumours. In addition, excisional biopsies are invasive, can’t be used repeatedly, and are ineffective in understanding the dynamics of tumor progression and metastasis. However, liquid biopsy, or blood-sample tests, under development by Epic Sciences can generate actionable information for oncologists by analysing circulating tumor cells (CTCs) and fragments of tumor-cell DNA that are continuously shed by tumours into the bloodstream. Highly sensitive analysis of individual CTCs have demonstrated a high level of heterogeneity seen at the single cell level for both protein expression and protein localization and the CTCs reflected both the primary biopsy and the changes seen in the metastatic sites. By detecting and quantifying genomic alterations in CTCs and cell-free DNA in blood, liquid biopsy can provide real-time information on the stage of tumor progression, treatment effectiveness, and cancer metastasis risk. This technological development could make it possible to diagnose and manage cancer from repeated blood tests rather than from a traditional biopsy. Building on the positive results from exploratory whole genome sequencing the analysis is narrowed down to specific bladder cancer-related genomic regions to enable both accurate and cost-efficient detection of bladder cancer from urine.

  • Bone marrow biopsy
  • Endoscopic biopsy
  • Needle biopsy
  • Excisional or incisional biopsy
  • Laparoscopic, thoracoscopic, and mediastinoscopic biopsy
  • Skin biopsy
  • Sentinel lymph node mapping and biopsy

Related Conference of Cancer Biopsy

Ljubljana Slovenia

ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia

21st to 23rd January 2016
Miami Florida United States of America

Miami 2016 Winter Symposium Miami United States of America

24th to 27th January 2016
Penang Malaysia

2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia

26th to 28th January 2016
Berlin Germany

ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany

5th to 6th February 2016
Pune Maharashtra India

3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India

5th to 7th February 2016
Hyderabad Telangana India

New and Emerging Trends In Oncology 2016 Hyderabad India

10th to 12th February 2016
Mumbai India

International Conference on Radiation Research Impact on Human Health and Environment Mumbai India

11th to 13th February 2016
Singapore

3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore

22nd to 23rd February 2016
Kuala Lumpur Malaysia

The Probiotics Congress Asia Kuala Lumpur Malaysia

29th February to 1st March 2016
San Francisco CA United States of America

Molecular Medicine Tri-Con 2016 San Francisco United States of America

6th to 11th March 2016

Cancer Biopsy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in